Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy

businesswire.com July 28, 2026 at 3:01 PM ET

NPCE NeuroPace received FDA guidance for expanding its indication to include idiopathic generalized epilepsy, a positive development for the company.